Streck Inc.

Research and Markets Offers Report North America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Wireless News; 12/20/2009; 592 words; ...CytoCore, Inc. - Daxor Corp. - IRIS International, Inc. - Meridian Bioscience, Inc. - Immucor, Inc. - Onconome, Inc. - Streck, Inc. - Targeted Diagnostics & Therapeutics, Inc. - + many more Report information: http://www...

Research and Markets Offers Report North America In Vitro Diagnostics Investment Opportunities
Wireless News; 12/20/2009; 579 words; ...CytoCore, Inc. - Daxor Corp. - IRIS International, Inc. - Meridian Bioscience, Inc. - Immucor, Inc. - Onconome, Inc. - Streck, Inc. - Targeted Diagnostics & Therapeutics, Inc. Report information: http://www.researchandmarkets...

Research and Markets Adds Report: North America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015.
Health & Beauty Close-Up; 12/16/2009; 705 words; ...CytoCore, Inc. - Daxor Corp. - IRIS International, Inc. - Meridian Bioscience, Inc. - Immucor, Inc. - Onconome, Inc. - Streck, Inc. - Targeted Diagnostics & Therapeutics, Inc. - + many more Report information: http://www.researchandmarkets...

Research and Markets Adds Report: North America In Vitro Diagnostics Investment Opportunities.
Health & Beauty Close-Up; 12/16/2009; 689 words; ...CytoCore, Inc. - Daxor Corp. - IRIS International, Inc. - Meridian Bioscience, Inc. - Immucor, Inc. - Onconome, Inc. - Streck, Inc. - Targeted Diagnostics & Therapeutics, Inc. Report information: http://www.researchandmarkets...

Patent No. 7,618,821 Issued on Nov. 17, Assigned to Streck for Simulated Blood Component (Nebraska Inventor)
US Fed News Service, Including US State News; 11/18/2009; 456 words; ...blood component. The inventor was issued U.S. Patent No. 7,618,821 on Nov. 17. The patent has been assigned to Streck Inc., LaVista, Neb. According to the abstract released by the U.S. Patent & Trademark Office: "A control and...